Retinoic acid and ifn inhibition of cell proliferation is associated with apoptosis in squamous carcinoma cell lines: Role of IRF-1 and tgase II- dependent pathways

Cell Growth and Differentiation

Volumn 8, Issue 1, 1997, Pages 91-100

  Giandomenico, Valeria ^a   Lancillotti, Francesca ^a   Fiorucci, Gianna ^a,b   Percario, Zulema A ^a   Rivabene, Roberto ^a   Malorni, Walter ^a   Affabris, Elisabetta ^a,c   Romeo, Giovanna ^a,b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b CNR   (Italy)

^c ROMA TRE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; REGULATOR PROTEIN; RETINOIC ACID; RETINOID; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER RESISTANCE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INDUCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA;

APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; DNA FRAGMENTATION; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GTP PHOSPHOHYDROLASES; GTP-BINDING PROTEINS; HUMANS; INTERFERON ALFA-2B; INTERFERON REGULATORY FACTOR-1; PHOSPHOPROTEINS; TRANSGLUTAMINASES; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0031032589     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. De Maeyer, E., and De Maeyer-Guignard, J. Interferons and other regulatory cytokines, p. 448. New York: John Wiley and Sons, 1988.
2. Romeo, G., Affabris, E., Battistini, A., and Rossi, G. B. Cell and animal effects of IFNs: natural occurrences, differentiation effects and mechanisms. In: S. Baron, D. H. Coppenhaver, F. Dianzani, W. R. Flaischmann, Jr., T. K. Hughes, Jr., G. R. Kumpel, D. W. Nielsen, G. J. Stanton, and S. K. Tyring (eds.), Interferon: Principles and Medical Applications, pp. 271-287. Galveston, TX: Texas Press, 1992.
3. Borden, E. C., and Sondel, P. M. Lymphokines and cytokines as cancer treatment: immunotherapy realized. Cancer (Phila.), 65: 800-814, 1990.
4. Moon, R. C., and Mehta, R. G. Retinoid inhibition of experimental carcinogenesis. In: M. I. Dawson and W. H. Okamura (eds.), Chemistry and Biology of Synthetic Retinoids, pp. 501-518. Boca Raton, FL: CRC Press, 1990.
5. Hong, W. K., and Itri, L M. Retinoids and human cancer. In: M. B. Sporn, A. B. Roberts, and D. S. Goodman (eds.), The Retinoids: Biology, Chemistry, and Medicine, pp. 597-658. New York: Raven Press, 1994.
6. Smith, M. A., Parkinson, D. R., Cheson, B. D., and Friedman, M. A. Retinoids in cancer therapy. J. Clin. Oncol., 10: 839-864, 1992.
7. Lippman, S. M., Glisson, B. S., Kavanagh, J. J., Lotan, R., Hong, W. K., Paredes-Espinoza, M., Hittelman, W. N., Holdener, E. E., and Krakoff, I. H. Retinoid acid and interferon combination studies in human cancer. Eur. J. Cancer, 29A: 9-13, 1993.
8. Lotan, R., Dawson, M. I., Zou, C-C., Jong, L., Lotan, D., and Zou, C-P. Enhanced efficacy of combinations of retinoic acid- and retinoid X receptor-selective retinoids and α-interferon in inhibition of cervical carcinoma cell proliferation. Cancer Res., 55: 232-236, 1995.
9. Lokshin, A., Mayotte, J. E., and Levitt, M. L. Mechanism of interferon-beta induced squamous differentiation and programmed cell death in human non-small-cell lung cancer cell lines. J. Natl. Cancer Inst., 87: 206-212, 1995.
10. Lancillotti, F., Giandomenico, V., Affabris, E., Fiorucci, G., Romeo, G., and Rossi, G. B. Interferon α-2b and retinoic acid combined treatment affects proliferation and gene expression of human cervical carcinoma cells. Cancer Res., 55: 3158-3164, 1995.
11. Chambon, P. The molecular and genetic dissection of the retinoid signaling pathway. Recent Prog. Horm. Res., 50: 317-332, 1995.
12. Darnell, J. E., Jr., Kerr, I. M., and Stark, G. R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science (Washington DC), 264: 1415-1421, 1994.
13. Folk, J. E. Transglutaminases. Annu. Rev. Biochem., 49: 517-531, 1980.
14. Floyd, E. E., and Jetten, A. M. Regulation of type I (epidermal) transglutaminase mRNA levels during squamous differentiation: down regulation by retinoids. Mol. Cell. Biol., 9: 4846-4851, 1989.
15. Eitan, S., and Schwartz, M. A transglutaminase that converts interleukin-2 into a factor cytotoxic to oligodendrocytes. Science (Washington DC), 261: 106-108, 1993.
16. Kojima, S., Nara, K., and Rifkin, D. B. Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells. J. Cell Biol., 121: 439-448, 1993.
17. Fesus, L., Thomazy, V., and Falus, A. Induction and activation of tissue transglutaminase during programmed cell death. FEBS Lett., 224: 104-108, 1987.
18. Piacentini, M., Fesus, L., Farrace, M. G., Ghibelli, L., Piredda, L., and Melino, G. The expression of tissue transglutaminase in two human cancer cell lines is related with the programmed cell death (apoptosis). Eur. J. Cell Biol., 54: 246-254, 1991.
19. Kerr, J. F. R., Searle, J., Harmon, B. V., and Bishop, C. J. Apoptosis. In: C. S. Potten (ed.), Perspective on Mammalian Cell Death, pp. 93-119. Oxford: Oxford Science Publication, 1987.
20. Davies, P. J. A, Stain, J. P., Chiocca, E. A., Basilion, J. P., Gentile, V., Thomazy, V., and Fesus, L. Retinoid-regulated expression of transglutaminases: links to the biochemistry of programmed cell death. In: G. Morriss-Kay (ed.), Retinoids in Normal Development and Teratogenesis, pp. 249-263. New York: Oxford University Press, 1992.
21. Zhang, L-X., Mills, K. J., Dawson, M. I., Collins, S. J., and Jetten, A. M. Evidence for the involvement of retinoic acid receptor RAR alpha-dependent signaling pathway in the induction of tissue transglutaminase and apoptosis by retinoids. J. Biol. Chem., 270: 6022-6029, 1995.
22. Williams, G. T., and Smith, C. A. Molecular regulation of apoptosis: genetic controls on cell death. Cell, 74: 777-779, 1993.
23. Rodriguez-Villanueva, J., and McDonnell, T. J. Induction of apoptotic cell death in non-melanoma skin cancer by interferon-alpha. Int. J. Cancer, 61: 110-114, 1995.
24. Benech, P., Mory Y., Revel M., and Chebath J. Structure of two forms of the interferon-induced (2′-5′) oligo A synthetase of human cells based on cDNAs and gene sequences. EMBO J., 4: 2249-2256, 1985.
25. Tanaka, N., Kawakami, T., and Taniguchi, T. Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Mol. Cell. Biol., 13: 4531-4538, 1993.
26. Tanaka, N., Ishihara, M., Kitagawa, M., Harada, H., Kimura, T., Matsuyama, T., Lamphier, M. S., Aizawa, S., Mak, T. W., and Taniguchi, T. Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell, 77: 829-839, 1994.
27. Tamura, T., Ishihara, M., Lamphier, M. S., Tanaka, N., Oishi, I., Aizawa, S., Matsuyama, T., Mak, T. W., Taki, S., and Taniguchi, T. An IRF-1 dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature (Lond.), 376: 596-599, 1995.
28. Bishop, J. M. Molecular themes in oncogenesis. Cell, 64: 235-248, 1991.
29. Evans, H. J. Molecular genetic aspects of human cancers: the 1993 Frank Rose lecture. Br. J. Cancer, 68: 1051-1060, 1993.
30. Harris, H. The role of differentiation in the suppression of malignancy. J. Cell Sci., 97: 5-10, 1990.
31. Puck, T. T., and Krystosek, A. Reverse transformation, genome exposure, and cancer. Adv. Cancer Res., 62: 125-151, 1993.
32. Cantley, L. C., Auger, K. R., Carpenter, C., Duckworth, B., Graziani, A., Kapeller, R., and Soltoff, S. Oncogenes and signal transduction. Cell, 64: 281-302, 1991.
33. Sonenberg, N. Translation factors as effectors of cell growth and tumorigenesis. Curr. Opin. Cell Biol., 5: 955-960, 1993.
34. McDonnell, T. J. Cell division versus cell death: a functional model of multistep neoplasia. Mol. Carcinog., 8: 209-213, 1993.
35. McDonnell, T. J., Meyn, R. E., and Robertson, L. E. Implications of apoptotic cell death regulation in cancer therapy. Semin. Cancer Biol., 6: 53-60, 1995.
36. Harada, H., Kitagawa, M., Tanaka, N., Yamamoto, H., Harada, K., Ishihara, M., and Taniguchi, T. Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science (Washington DC) 259: 971-974, 1993.
37. Eckert, R. L. Structure, function, and differentiation of the keratrnocyte. Physiol. Rev., 69: 1316-1346, 1989.
38. Piacentini, M., Autuori, F., Dini, L., Farrace, M. G., Ghibelli, L., Piredda, L., and Fesus, L. Tissue transglutaminase is specifically expressed in neonatal rat liver cells undergoing apoptosis upon epidermal growth factor-stimulation. Cell Tissue Res., 263: 227-235, 1991.
39. Ruoslahti, E., and Reed, J. C. Anchorage dependence, integrins, and apoptosis. Cell, 77: 477-478, 1994.
40. Boudreau, N., Sympson, C. J., Web, Z., and Bissell, M. J. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science (Washington DC), 267: 891-893, 1995.
41. Malorni, W., Rivabene, R., Straface, E., Rainaldi, G., Cossarizza, A., Monti, D., Salvioli, S., and Franceschi, C. 3-Aminobenzamide protects cells from UV-B-induced apoptosis by acting on cytoskeleton and substrate adhesion. Biochem. Biophys. Res. Commun., 207: 715-724, 1995.
42. Glisin, V., Crkvenjakov, R., and Byus, C. Ribonucleic acid isolated by cesium chloride centrifugation. Biochemistry, 13: 2633-2637, 1974.
43. Jetten, A. M., and Shirley, J. Characterization of transglutaminase activity in rabbit tracheal epithelial cells. Regulation by retinoids. J. Biol. Chem., 261: 15097-15101, 1986.
44. Laurent-Crawford, A. G., Krust, B., Muller, S., Rivière, Y., Rey-Cuillé, M. A., Bèchet, J. M., Montagnier, L., and Hovanessian, A. G. The cytopathic effect of HIV is associated with apoptosis. Virology, 185: 829-839, 1986.
45. Bursch, W., Oberhammer, F., and Schulte-Hemann, R. Cell death by apoptosis and its protective role against disease. Trends Pharmacol. Sci., 13: 245-251, 1992.